Warning! GuruFocus detected
1 Severe warning sign
with ABIO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
ARCA biopharma Inc
NAICS : 325413
SIC : 2835
ISIN : US00211Y4070
Description
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 163.15 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 37.5 | |||||
| 3-Year EPS without NRI Growth Rate | 43.7 | |||||
| 3-Year FCF Growth Rate | 40.4 | |||||
| 3-Year Book Growth Rate | -19.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.51 | |||||
| 9-Day RSI | 29 | |||||
| 14-Day RSI | 34.3 | |||||
| 6-1 Month Momentum % | 81.82 | |||||
| 12-1 Month Momentum % | 45.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 26.61 | |||||
| Quick Ratio | 26.61 | |||||
| Cash Ratio | 26.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.9 | |||||
| Shareholder Yield % | 0.02 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -19.79 | |||||
| ROA % | -19.08 | |||||
| ROIC % | -3003.62 | |||||
| 3-Year ROIIC % | -271.36 | |||||
| ROC (Joel Greenblatt) % | -5170.44 | |||||
| ROCE % | -25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.95 | |||||
| Price-to-Tangible-Book | 0.95 | |||||
| EV-to-EBIT | -43.07 | |||||
| EV-to-EBITDA | -43.46 | |||||
| EV-to-FCF | -57.1 | |||||
| Price-to-Net-Current-Asset-Value | 0.95 | |||||
| Price-to-Net-Cash | 0.97 | |||||
| Earnings Yield (Greenblatt) % | -2.32 | |||||
| FCF Yield % | -1.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ABIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ARCA biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -6 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.1 | ||
| Volatility % | 108.24 | ||
| 14-Day RSI | 34.3 | ||
| 14-Day ATR ($) | 4.919591 | ||
| 20-Day SMA ($) | 38.205 | ||
| 12-1 Month Momentum % | 45.64 | ||
| 52-Week Range ($) | 18.72 - 53.88 | ||
| Shares Outstanding (Mil) | 1.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ARCA biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ARCA biopharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ARCA biopharma Inc Frequently Asked Questions
What is ARCA biopharma Inc(ABIO)'s stock price today?
The current price of ABIO is $25.50. The 52 week high of ABIO is $53.88 and 52 week low is $18.72.
When is next earnings date of ARCA biopharma Inc(ABIO)?
The next earnings date of ARCA biopharma Inc(ABIO) is 2025-08-01 Est..
Does ARCA biopharma Inc(ABIO) pay dividends? If so, how much?
ARCA biopharma Inc(ABIO) does not pay dividend.
Guru Commentaries on NAS:ABIO
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers